This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ADSTILADRIN
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Conference Highlights
AUA 2018
AUA 2018
Prostate Cancer
Bladder Cancer
Renal Cancer
Testis & Penile Cancers
Lower Urinary Tract Conditions / Nocturia
GU Reconstruction
Infections & Inflammation
Laparoscopic / Robotic Surgery
Sexual Function
Stone Disease
Press Releases
AUA 2018 Renal Cancer
Viewing 41-60 of 90 articles
AUA 2018: Evaluation of Bacterial Biofilms on Renal Calculi
AUA 2018: Diagnostic Value of 68GA-Labelled PSMA PET/CT Imaging for Renal Cell Carcinoma
AUA 2018: Office-Based Ultrasound-Guided Percutaneous Renal Mass Biopsy
AUA 2018: Characterizing the Incidence, Predictors, and Survival of Disappearing Renal Tumors from the DISSRM Registry
AUA 2018: Shared Decision Making for Treatment of Small Renal Masses: a Survey of Patients' Opinions Before and After Initial Counseling
AUA 2018: Comparison Between Liver Derotation with Pringle Manoeuvre and Cardiopulmonary Bypass with Deep-Hypothermic Cardiac Arrest for Kidney Cancer with Mayo Level III Tumor Thrombus
AUA 2018: Effect of African-American Race on Cancer Specific Mortality Differs According to Clear-Cell vs Non-Clear Cell Histologic Subtype in Metastatic Renal Cell Carcinoma
AUA 2018: Oncological and Functional Outcomes in Minimally Invasive Approach for Kidney Cancer with Venous Thrombus
AUA 2018: Outcomes of Partial Versus Radical Nephrectomy in Octogenarian Patients: Results from the RESURGE Project
AUA 2018: On-Clamp vs Off-Clamp Partial Nephrectomy: Propensity Score Matched Comparison of Long Term Functional Outcomes
AUA 2018: Variability in Partial Nephrectomy Outcomes: Does Your Surgeon Matter?
AUA 2018: Does Partial Nephrectomy for Biopsy Proven Fuhrman Grade 3/4 Renal Cell Carcinoma Confer Worse Outcomes Compared to Radical Nephrectomy?
AUA 2018: Oncologic Outcomes of Simple Enucleation Partial Nephrectomy in Sporadic Type 2 Papillary Renal Cell Carcinoma
AUA 2018: Frozen Sections for Margins During Partial Nephrectomy Do Not Influence Recurrence Rates
AUA 2018: Surgical Techniques: Tips & Tricks: Dissection of the Renal Mass with Hilar Fat Invasion
AUA 2018: Tips and Tricks – Open Partial Nephrectomy
AUA 2018: Comparative Analysis of Minimally Invasive Radical and Partial Nephrectomy for Clinical T2 Renal Mass: Analysis of the Robotic Surgery for Large Renal Mass (ROSULA) Group
AUA 2018: Complex Cases: Locally Advanced and Metastatic Kidney Cancer
AUA 2018: Outcomes of Synchronous and Metachronous Bilateral Small Renal Masses (4cm)
AUA 2018: Long-Term Active Surveillance of Complex Cystic Renal Masses & the Heterogeneity of BOSNIAK 3 Lesions
1
2
3
4
5
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free